Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Misguided Use of HCQ for COVID-19

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston May 17, 2021 9:27am

89 Views

Post# 33213159

RE:RE:RE:RE:Misguided Use of HCQ for COVID-19

What was funny is that Trump, when diagnosed with COVID-19, he was not given HCQ. Why? Because his doctors told him it was not efficicent.

But Bungee/Pandora bagholders continued to promote HCQ, while having no scientific ground, apart their libertarian views, that we all agree are worth nothing, because not supported by rigorous standards.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?